Connect with us

Hi, what are you looking for?

Consumer Empowered Health

App Launched Which Could Halve Post-Surgery Complication Rates

App Launched Which Could Halve Post-Surgery Complication Rates

According to a range of scientific studies, up to 30% of surgical patients experience complications after surgery, meaning increased healthcare costs, hospital stays and bed occupation. With COVID-19 leading to huge waiting lists and a backlog of elective surgery, the need to find ways of improving efficiency, reducing complications and length of stay has never been more essential.

myOp is an all-in-one solution supporting patients and clinicians from the decision-to-operate to a full, speedy recovery. It delivers a variety of ‘prehabilitation’ interventions that have been shown to reduce complication rates by up to 50%. my mhealth has selected the most effective, evidence-based tools, combined with proven behavioural change techniques to deliver tailored care to patients.

The app follows a model of prehabilitation broken down into three key areas: nutrition, exercise and anxiety. Patients can increase their fitness at a level appropriate to them, and a custom-designed mindfulness-based cognitive therapy course is in-app. With educational content, memory aids that support patient concerns and a nutrition section – myOp is packed full of videos and content that help patients to prepare well for surgery.

It also supports clinicians by providing a series of screening tools that allow rapid assessment of patient risk and identify those at a higher risk of post-op complications.

Surgical Expert at my mhealth and myOp creator, Dr Harry Thirkettle, said: “I’ve seen first-hand that the impact of post-surgery complications on both patients and healthcare systems can be catastrophic. These complications can have lifelong impact on patients and greatly increase the cost of care, as well as stress levels and pressure on clinical teams. They also have indirect ramifications due to patients staying in hospital longer. This problem was something that I was passionate about solving. myOp was born from my desire to create something that could be widely used and given to every patient undergoing major elective surgery to give them the tools they needed to prepare. After seven years in the making, I could not be more thrilled to launch this ground-breaking digital therapeutic.”

Professor Mike Grocott, professor of anaesthesia and critical care medicine at the University of Southampton, said: “Effective prehabilitation has been shown to reduce complications and improve quality of life. As the health service recovers from the COVID-19 pandemic it is now more important than ever to support and optimise patients pre-operatively complications, shorter hospital stays and improved efficiency in surgical pathways. Prehabilitation and enhanced recovery after surgery should form a key part of current elective recovery plans.”

Seen on Med-Tech Innovation News: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

BioTechnology

Baleon Capital, a one-year-old venture capital firm started by investment veteran Jon Kaiden, closed its first fund to invest in pre-Series A and Series...

Artificial Intelligence

The Asian digital health market is expected to be worth up to $100 billion by 2025.

Digital Health

Today, BoxGroup is announcing it has beefed up its war chest so that it can be that “first yes” to more companies with the...

CE Mark

Paragonix SherpaPak® CTS is the only commercially available FDA-cleared and CE-marked medical device for heart transportation and the only device to fit small pediatric...

You May Also Like

Artificial Intelligence

Digital Solutions In Healthcare Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare industry by storm....

Digital Health

The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.

COVID-19

In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...

Artificial Intelligence

Joe Mullings discusses the Microbot – Liberty robotic platform with Harel Gadot and how a new category of surgical robotics creates a new entry...